Search results
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 11 hours agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 1 day agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study ...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 2 days agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
US government, Moderna nearing deal for bird flu vaccine funding: reports
The Hill via Yahoo News· 5 days agoThe U.S. government is reportedly close to finalizing a deal with Moderna to fund its bird flu mRNA ...
Moderna Investors Just Got Some Bullish News | The Motley Fool
The Motley Fool· 2 days agoModerna (MRNA 3.70%) jumped into the limelight when it started developing a coronavirus vaccine...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 1 day agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
Moderna's mRNA bird flu vaccine trial is close to getting U.S. government funding
Quartz· 5 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 2 days agoIn 2023, Moderna agreed to establish an mRNA manufacturing facility in Kenya. The new advanced facility will have the capacity to produce up to 500...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 2 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 4 days agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year — ...